154 related articles for article (PubMed ID: 2009375)
1. Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. The Northern Regional Bone Marrow Transplant Group.
Carey PJ; Proctor SJ; Taylor P; Hamilton PJ
Blood; 1991 Apr; 77(7):1593-8. PubMed ID: 2009375
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
Jackson GH; Lennard AL; Taylor PR; Carey P; Angus B; Lucraft H; Evans RG; Proctor SJ
Br J Cancer; 1994 Sep; 70(3):501-5. PubMed ID: 7521662
[TBL] [Abstract][Full Text] [Related]
3. Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.
Taylor PR; Jackson GH; Lennard AL; Lucraft H; Proctor SJ
Br J Cancer; 1993 Feb; 67(2):383-7. PubMed ID: 8431371
[TBL] [Abstract][Full Text] [Related]
4. Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-up.
Mehta J; Powles R; Treleaven J; Horton C; Shepherd V; Hale G; Waldmann H; Singhal S
Leuk Lymphoma; 1997 May; 25(5-6):479-86. PubMed ID: 9250818
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
Freedman AS; Takvorian T; Neuberg D; Mauch P; Rabinowe SN; Anderson KC; Soiffer RJ; Spector N; Grossbard M; Robertson MJ
J Clin Oncol; 1993 May; 11(5):931-6. PubMed ID: 8487057
[TBL] [Abstract][Full Text] [Related]
6. Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.
Phillips GL; Shepherd JD; Barnett MJ; Lansdorp PM; Klingemann HG; Spinelli JJ; Nevill TJ; Chan KW; Reece DE
J Clin Oncol; 1991 Oct; 9(10):1880-8. PubMed ID: 1919638
[TBL] [Abstract][Full Text] [Related]
7. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
8. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging.
Billett AL; Sallan SE
Am J Pediatr Hematol Oncol; 1993 May; 15(2):162-8. PubMed ID: 8498641
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma.
Schouten HC; Colombat P; Verdonck LF; Gorin NC; Björkstrand B; Taghipour G; Goldstone AH
Ann Oncol; 1994; 5 Suppl 2():147-9. PubMed ID: 8204514
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Johnston LJ; Stockerl-Goldstein KE; Hu WW; Negrin RS; Hoppe RT; Blume KG; Horning SJ
Biol Blood Marrow Transplant; 2000; 6(5A):555-62. PubMed ID: 11071261
[TBL] [Abstract][Full Text] [Related]
12. Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma.
Prince HM; Crump M; Imrie K; Stewart AK; Girouard C; Brandwein JM; Carstairs K; Pantalony D; Scott G; Sutcliffe S; Sutton DM; Tsang R; Keating A
Ann Oncol; 1996 Dec; 7(10):1043-9. PubMed ID: 9037363
[TBL] [Abstract][Full Text] [Related]
13. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.
Bonetti F; Zecca M; Pession A; Messina C; Montagna D; Lanino E; Fagioli F; Santoro N; Prete A; Cesaro S; Rondelli R; Giorgiani G; De Stefano P; Locatelli F
J Clin Oncol; 1999 Dec; 17(12):3729-35. PubMed ID: 10577844
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
[TBL] [Abstract][Full Text] [Related]
15. The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.
Prince HM; Imrie K; Crump M; Stewart AK; Girouard C; Colwill R; Brandwein J; Tsang RW; Scott JG; Sutton DM; Pantalony D; Carstairs K; Sutcliffe SB; Keating A
Br J Haematol; 1996 Mar; 92(4):880-9. PubMed ID: 8616081
[TBL] [Abstract][Full Text] [Related]
16. Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.
Philip T; Chauvin F; Armitage J; Bron D; Hagenbeek A; Biron P; Spitzer G; Velasquez W; Weisenburger DD; Fernandez-Ranada J
Blood; 1991 Apr; 77(7):1587-92. PubMed ID: 2009374
[TBL] [Abstract][Full Text] [Related]
17. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia.
Tiley C; Powles R; Treleaven J; Catovsky D; Milan S; Teo CP; Catalano J; Mehta J; Shields M; Gupta P
Bone Marrow Transplant; 1993 Nov; 12(5):449-55. PubMed ID: 8298555
[TBL] [Abstract][Full Text] [Related]
20. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.
Vose JM; Bierman PJ; Anderson JR; Kessinger A; Pierson J; Nelson J; Frappier B; Schmit-Pokorny K; Weisenburger DD; Armitage JO
Blood; 1992 Oct; 80(8):2142-8. PubMed ID: 1356515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
